
3 Diesel Engines Maker, Pharma Ingredients Maker and Steel Wheels Maker Stocks With a Strong Future Roadmap: Kirloskar Oil Engines, Laurus Labs and Wheels India
Kirloskar Oil Engines, Laurus Labs and Wheels India: ROE of 14.9% to 16.8% and FY22 to FY26 revenue CAGR of 8.4% to 17.7%. Prices as of 18 Nov 2026.
Updated: 19 Nov 2026 • 4:07 pm
Posted by:

Quick Answer
The three diesel engine, drug API and steel wheel stocks to watch are Kirloskar Oil Engines, Laurus Labs and Wheels India. Their return on equity ranges from 14.9% to 16.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.4% to 17.7%. Laurus Labs has the highest return on equity at 16.8%, while Kirloskar Oil Engines has the fastest revenue growth at 17.7% a year. Prices are based on the 18 November 2026 close, and this article is educational, not investment advice.
Diesel engine, drug API and steel wheel stocks bring together companies with a visible plan for the years ahead. Kirloskar Oil Engines, Laurus Labs and Wheels India cover a diesel engines maker, a pharma ingredients maker and a steel wheels maker.
This list covers three diesel engine, drug API and steel wheel stocks with complete current figures: Kirloskar Oil Engines, Laurus Labs and Wheels India. Every figure comes from the latest reported financials and the 18 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Diesel Engine, Drug API and Steel Wheel Stocks?
Diesel engine, drug API and steel wheel stocks are listed companies that make diesel engines and generators for farms, buildings and industry, make active drug ingredients and finished medicines, and make steel wheels for trucks, tractors and cars. Their earnings depend on engine orders, drug orders and vehicle output.
Diesel Engine, Drug API and Steel Wheel Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Kirloskar Oil Engines | 1,661.4 | 28,722 | 53.7 | 44.4 | 15.9 | 1.48 |
| Laurus Labs | 2,322.5 | 111,434 | 102.2 | 36.0 | 16.8 | 0.48 |
| Wheels India | 2,294.8 | 6,549 | 39.4 | 36.9 | 14.9 | 0.74 |
On valuation, all three trade at a P/E above their industry P/E, which reflects the growth the market already expects from them. Readers comparing diesel engine, drug API and steel wheel stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in diesel engine, drug API and steel wheel stocks can use the coming numbers to test whether growth is holding.
Why Do Diesel Engine, Drug API and Steel Wheel Stocks Have a Strong Roadmap in India?
Diesel engine, drug API and steel wheel stocks have a strong roadmap in India because strong demand for backup power, rising outsourcing of drug making and steady truck and tractor output keep widening the market for these companies.
- Diesel engines. Buildings and farms need backup power.
- Drug ingredients. Drug makers source from reliable plants.
- Steel wheels. Trucks and tractors need strong wheels.
Why Kirloskar Oil Engines Features Among These Diesel Engine, Drug API and Steel Wheel Stocks
Among the diesel engine, drug API and steel wheel stocks on this list, Kirloskar Oil Engines, based in Pune, makes diesel and gas engines, generator sets, pumps and power solutions for industrial, farm and infrastructure use.
The company has a return on equity of 15.9%, a debt to equity ratio of 1.48 and a market capitalisation of Rs 28,722 crore. The stock trades at a P/E of 53.7, above the industry P/E of 44.4.
Revenue rose from Rs 4,049 crore in FY22 to Rs 7,772 crore in FY26, a compound annual growth rate of 17.7%. Net profit grew from Rs 171 crore in FY22 to Rs 558 crore in FY26, which works out to a compound annual growth rate of 34.4%. In the June 2026 quarter, revenue grew 12.1% year on year to Rs 2,015 crore.
Roadmap: Backup power demand from data centres, telecom and infrastructure, a growing exports business and new alternative-fuel engines give it several tracks for growth. A large service network helps it hold on to customers across product cycles.
What to watch: Watch order intake from data centres and the pace of new product launches in cleaner fuels.
Why Laurus Labs Features Among These Diesel Engine, Drug API and Steel Wheel Stocks
Among the genset maker, drug ingredient and vehicle wheel shares on this list, Laurus Labs is a Hyderabad-based pharmaceutical company with businesses in active ingredients, finished formulations, custom synthesis and biotechnology, with a leading position in anti-retroviral medicines.
Revenue rose from Rs 4,951 crore in FY22 to Rs 6,868 crore in FY26, a compound annual growth rate of 8.5%. Net profit for FY26 was Rs 890 crore, a net margin of 13.0%.
In the June 2026 quarter, revenue grew 28.8% year on year to Rs 2,035 crore, while net profit rose 124.7% to Rs 362 crore. The company has a return on equity of 16.8%, a debt to equity ratio of 0.48 and a market capitalisation of Rs 111,434 crore. The stock trades at a P/E of 102.2, above the industry P/E of 36.0.
Roadmap: The company has widened its range from anti-retroviral ingredients into oncology, cardiac and other therapies and has added capacity in formulations. Its custom synthesis and biotechnology arms add exposure to services for global drug developers.
What to watch: Follow the ramp-up of new capacity in formulations and the order flow in custom synthesis.
Why Wheels India Features Among These Diesel Engine, Drug API and Steel Wheel Stocks
Among the three companies on this list, Wheels India, based in Chennai, manufactures steel wheels for commercial vehicles, tractors and off-highway machines, and is part of the Amalgamations group.
In the June 2026 quarter, revenue grew 17.7% year on year to Rs 1,493 crore, while net profit rose 27.3% to Rs 38.9 crore. Revenue rose from Rs 3,979 crore in FY22 to Rs 5,488 crore in FY26, a compound annual growth rate of 8.4%.
Net profit grew from Rs 74.2 crore in FY22 to Rs 158 crore in FY26, which works out to a compound annual growth rate of 20.8%. The company has a return on equity of 14.9%, a debt to equity ratio of 0.74 and a market capitalisation of Rs 6,549 crore. The stock trades at a P/E of 39.4, above the industry P/E of 36.9.
Roadmap: Demand from trucks, tractors and construction equipment, along with exports and a growing aftermarket, supports its volumes. The company is also working on lighter wheels and new products for farm and construction machines.
What to watch: Follow farm and construction equipment demand and steel prices.
Kirloskar Oil Engines vs Laurus Labs vs Wheels India on Key Financials
The table below sets the three diesel engine, drug API and steel wheel stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Kirloskar Oil Engines | 4,049 | 7,772 | 17.7% | 558 | 7.2% |
| Laurus Labs | 4,951 | 6,868 | 8.5% | 890 | 13.0% |
| Wheels India | 3,979 | 5,488 | 8.4% | 158 | 2.9% |
Laurus Labs posts the highest return on equity in this group at 16.8%. Kirloskar Oil Engines combines the largest FY26 revenue at Rs 7,772 crore with the fastest revenue growth, a 17.7% compound annual rate. A useful habit with diesel engine, drug API and steel wheel stocks is to check each new quarterly result against the capacity plans the company described earlier. Many investors spread money across several engines and gensets, pharma ingredients and wheels stocks instead of one name, which keeps a single result from deciding the outcome.
The June 2026 quarter, the latest reported, gives a fresh read on momentum:
| Company | Q1 FY26 Revenue (Rs Cr) | Q1 FY27 Revenue (Rs Cr) | Year-on-Year Growth |
|---|---|---|---|
| Kirloskar Oil Engines | 1,796 | 2,015 | 12.1% |
| Laurus Labs | 1,580 | 2,035 | 28.8% |
| Wheels India | 1,269 | 1,493 | 17.7% |
Key Risks to Check Before Investing in Diesel Engine, Drug API and Steel Wheel Stocks
Every theme carries risks that deserve a check before any decision. For these diesel engine, drug API and steel wheel stocks, the main points are: Long-term genset maker, drug ingredient and vehicle wheel shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Order timing. Project awards can shift between periods.
- Regulatory approvals. Plant inspections and approvals can affect supplies.
- Demand cycles. Sales can vary with seasons and rates.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter diesel engine, drug API and steel wheel stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Diesel Engine, Drug API and Steel Wheel Stocks
Diesel engine, drug API and steel wheel stocks suit investors who prefer to study business strength before price moves. Kirloskar Oil Engines, Laurus Labs and Wheels India each have a clear plan to grow. Based on the 18 November 2026 close, Kirloskar Oil Engines trades at Rs 1,661.4, Laurus Labs at Rs 2,322.5 and Wheels India at Rs 2,294.8. Valuation matters as much as growth, so compare each company's P/E with its industry P/E before adding any of these diesel engine, drug API and steel wheel stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track diesel engine, drug API and steel wheel stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are diesel engine, drug API and steel wheel stocks?
Ans. Diesel engine, drug API and steel wheel stocks are listed companies that make diesel engines and generators for farms, buildings and industry, make active drug ingredients and finished medicines, and make steel wheels for trucks, tractors and cars. Their earnings depend on engine orders, drug orders and vehicle output. This list looks at three of them, Kirloskar Oil Engines, Laurus Labs and Wheels India, using reported FY22 to FY26 financials and the 18 November 2026 closing prices.
Which diesel engine, drug API and steel wheel stocks are covered in this list?
Ans. This list covers Kirloskar Oil Engines, Laurus Labs and Wheels India. Based on the 18 November 2026 close, Kirloskar Oil Engines traded at Rs 1,661.4, Laurus Labs at Rs 2,322.5 and Wheels India at Rs 2,294.8. Their return on equity ranges from 14.9% to 16.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.4% to 17.7%.
Why do diesel engine, drug API and steel wheel stocks have a strong future roadmap in India?
Ans. Diesel engine, drug API and steel wheel stocks have a strong roadmap in India because strong demand for backup power, rising outsourcing of drug making and steady truck and tractor output keep widening the market for these companies. The main drivers are as follows. Diesel engines. Buildings and farms need backup power. Drug ingredients. Drug makers source from reliable plants. Steel wheels. Trucks and tractors need strong wheels. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Kirloskar Oil Engines performed financially?
Ans. Revenue rose from Rs 4,049 crore in FY22 to Rs 7,772 crore in FY26, a compound annual growth rate of 17.7%. Net profit grew from Rs 171 crore in FY22 to Rs 558 crore in FY26, which works out to a compound annual growth rate of 34.4%. In the June 2026 quarter, revenue grew 12.1% year on year to Rs 2,015 crore. The company has a return on equity of 15.9%, a debt to equity ratio of 1.48 and a market capitalisation of Rs 28,722 crore. The stock trades at a P/E of 53.7, above the industry P/E of 44.4. Looking ahead, backup power demand from data centres, telecom and infrastructure, a growing exports business and new alternative-fuel engines give it several tracks for growth. A large service network helps it hold on to customers across product cycles.
How has Laurus Labs performed financially?
Ans. Revenue rose from Rs 4,951 crore in FY22 to Rs 6,868 crore in FY26, a compound annual growth rate of 8.5%. Net profit for FY26 was Rs 890 crore, a net margin of 13.0%. In the June 2026 quarter, revenue grew 28.8% year on year to Rs 2,035 crore, while net profit rose 124.7% to Rs 362 crore. The company has a return on equity of 16.8%, a debt to equity ratio of 0.48 and a market capitalisation of Rs 111,434 crore. The stock trades at a P/E of 102.2, above the industry P/E of 36.0. Looking ahead, the company has widened its range from anti-retroviral ingredients into oncology, cardiac and other therapies and has added capacity in formulations. Its custom synthesis and biotechnology arms add exposure to services for global drug developers.
How has Wheels India performed financially?
Ans. Revenue rose from Rs 3,979 crore in FY22 to Rs 5,488 crore in FY26, a compound annual growth rate of 8.4%. Net profit grew from Rs 74.2 crore in FY22 to Rs 158 crore in FY26, which works out to a compound annual growth rate of 20.8%. In the June 2026 quarter, revenue grew 17.7% year on year to Rs 1,493 crore, while net profit rose 27.3% to Rs 38.9 crore. The company has a return on equity of 14.9%, a debt to equity ratio of 0.74 and a market capitalisation of Rs 6,549 crore. The stock trades at a P/E of 39.4, above the industry P/E of 36.9. Looking ahead, demand from trucks, tractors and construction equipment, along with exports and a growing aftermarket, supports its volumes. The company is also working on lighter wheels and new products for farm and construction machines.
What risks should investors check before buying diesel engine, drug API and steel wheel stocks?
Ans. Investors should check a few risks before buying diesel engine, drug API and steel wheel stocks. Order timing. Project awards can shift between periods. Regulatory approvals. Plant inspections and approvals can affect supplies. Demand cycles. Sales can vary with seasons and rates. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of diesel engine, drug API and steel wheel stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 18 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.
Recent Articles

Top Under Rs 1,200 Stocks Compared: Kalyan Jewellers vs CG Power vs Infosys vs Max Healthcare vs Metro Brands on Price, Valuation, Q2 FY27 Results and Risks
19 November 2026

Top Under Rs 600 Stocks Compared: IRCTC vs Berger Paints vs Aarti Industries vs Honasa Consumer vs Vardhman Textiles on Price, Valuation, Q2 FY27 Results and Risks
19 November 2026

Top Under Rs 400 Stocks Compared: ITC vs NTPC vs KEC International vs Chambal Fertilisers vs Dabur on Price, Valuation, Q2 FY27 Results and Risks
19 November 2026

Top Mid-Cap High-Dividend Stocks Compared: Chennai Petroleum vs IGL vs Petronet LNG vs Emami vs Container Corporation on Price, Valuation, Q2 FY27 Results and Risks
19 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Top Under Rs 1,200 Stocks Compared: Kalyan Jewellers vs CG Power vs Infosys vs Max Healthcare vs Metro Brands on Price, Valuation, Q2 FY27 Results and Risks
Top Under Rs 600 Stocks Compared: IRCTC vs Berger Paints vs Aarti Industries vs Honasa Consumer vs Vardhman Textiles on Price, Valuation, Q2 FY27 Results and Risks
Top Under Rs 400 Stocks Compared: ITC vs NTPC vs KEC International vs Chambal Fertilisers vs Dabur on Price, Valuation, Q2 FY27 Results and Risks
Top Mid-Cap High-Dividend Stocks Compared: Chennai Petroleum vs IGL vs Petronet LNG vs Emami vs Container Corporation on Price, Valuation, Q2 FY27 Results and Risks
Top Small-Cap High-Margin Stocks Compared: IEX vs Lemon Tree Hotels vs Vijaya Diagnostic vs Pokarna vs SCI on Price, Valuation, Q2 FY27 Results and Risks

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





